Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G

Mfold web server for nucleic acid folding and hybridization prediction

Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687

Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics

Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Bond, C. E., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J. H., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,072

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 931

Evolutionary changes in cis and trans gene regulation

Wittkopp, P. J., Haerum, B. K., & Clark, A. G. (2004) · Nature · doi:10.1038/nature02698 · Cited by 873

Endogenous opioid systems and alcohol addiction

Herz, A. (1997) · Psychopharmacology · doi:10.1007/s002130050169 · Cited by 755

A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients

Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571

Allelic Variation in Gene Expression Is Common in the Human GenomePreprint

Lo, H. S., Wang, Z., Hu, Y., Yang, H. H., Gere, S., Buetow, K. H., & Lee, M. P. (2003) · Genome Research · doi:10.1101/gr.1006603 · Cited by 446

A Haplotype Implicated in Schizophrenia Susceptibility Is Associated with Reduced COMT Expression in Human Brain

Bray, N. J., Buckland, P. R., Williams, N. M., Williams, H. J., Norton, N., Owen, M. J., & O’Donovan, M. C. (2003) · The American Journal of Human Genetics · doi:10.1086/376578 · Cited by 335

Lack of Association of OPRM1 Genotype and Smoking Cessation

Munafo, M. R., Johnstone, E. C., Aveyard, P. N., & Marteau, T. M. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts174 · Cited by 19

Promising Pharmacogenetic Targets for Treating Alcohol Use Disorder: Evidence from Preclinical Models

Rinker, J. A., & Mulholland, P. J. (2017) · Pharmacogenomics · doi:10.2217/pgs-2016-0193 · Cited by 18

OPRM1 A118G and serum β-endorphin interact with sex and digit ratio (2D:4D) to influence risk and course of alcohol dependence

Gegenhuber, B., Weinland, C., Kornhuber, J., Mühle, C., & Lenz, B. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.09.002 · Cited by 19

The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity

Bruehl, S. P., Chung, O. Y., & Burns, J. W. (2008) · Pain · doi:10.1016/j.pain.2008.05.014 · Cited by 19

Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment

Lee, A. M., & Tyndale, R. F. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066039 · Cited by 19

A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane μ-Opioid Receptor through Heterodimerization

Zhang, T., Xu, J., & Pan, Y. (2020) · Molecular Pharmacology · doi:10.1124/mol.120.119453 · Cited by 18

Genetic Variants Associated With Opioid Use Disorder

Freiermuth, C. E., Kisor, D. F., Lambert, J., Braun, R. S., Frey, J. A., Bachmann, D., Bischof, J. J., Lyons, M. S., Pantalon, M. V., Punches, B. E., et al. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2864 · Cited by 18

Pharmacogenomics in pain treatment

Peiró, A. M., Planelles, B., Juhász, G., Bagdy, G., Libert, F., Eschalier, A., Busserolles, J., Sperlágh, B., & LLerena, A. (2016) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2016-0005 · Cited by 18

The influence of the OPRM1 (A118G) polymorphism on behavioral and neural correlates of aggression in healthy males

Weidler, C., Wagels, L., Regenbogen, C., Hofhansel, L., Blendy, J. A., Clemens, B., Montag, C., & Habel, U. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.12.014 · Cited by 18

The G Allele of SNP E1/A118G at the µ-Opioid Receptor Gene Locus Shows Genomic Evidence of Recent Positive Selection

Pang, G. S., Wang, J., Wang, Z., Goh, C. R., & Lee, C. G. L. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.63 · Cited by 18

OPRM1 Gene Is Associated With BMI in Uyghur Population

Xu, L., Zhang, F., Zhang, D., Chen, X., Lü, M., Lin, R., Wen, H., Li, J., & Wang, X. (2008) · Obesity · doi:10.1038/oby.2008.504 · Cited by 18

Opioid system modulation of cognitive affective bias: implications for the treatment of mood disorders

Varastehmoradi, B., Wegener, G., Sánchez, C., & Smith, K. L. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000559 · Cited by 17

Drug Therapy and Personalized Health Care: Pharmacogenomics in Perspective

Sadée, W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9702-4 · Cited by 18

Pharmacogenetically Driven Treatments for Alcoholism

Arias, A. J., & Sewell, R. A. (2012) · CNS Drugs · doi:10.2165/11633180-000000000-00000 · Cited by 16

Biomarkers to Optimize the Treatment of Nicotine Dependence

Schnoll, R. A., & Leone, F. T. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.91 · Cited by 17

The Pharmacogenetics of Opioid Therapy in the Management of Postpartum Pain: A Systematic Review

Baber, M., Bapat, P., Nichol, G., & Koren, G. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.157 · Cited by 17

A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology

Bernardi, R. E., Zohsel, K., Hirth, N., Treutlein, J., Heilig, M. A., Laucht, M., Spanagel, R., & Sommer, W. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.132 · Cited by 17

The pharmacogenetics of opioid treatment for pain management

Singh, A., Zai, C. C. H., Mohiuddin, A. G., & Kennedy, J. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120944162 · Cited by 17

Association analysis between the A118G polymorphism in the OPRM1 gene and treatment response to venlafaxine XR in generalized anxiety disorder

Cooper, A. J., Rickels, K., & Lohoff, F. W. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2317 · Cited by 17

Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Population

Francès, F., Portolés, O., Ponce, A. C., Costa, J. A., & Verdú, F. (2015) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2015.243 · Cited by 17

Genotyping Test with Clinical Factors: Better Management of Acute Postoperative Pain?

Hajj, A., Peoc’h, K., Laplanche, J., Jabbour, K., Naccache, N., Zeid, H. A., Yazbeck, P. H., & Khabbaz, L. R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036298 · Cited by 17

Rhesus monkey tryptophan hydroxylase-2 coding region haplotypes affect mRNA stability

Chen, G.-L., & Miller, G. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.050 · Cited by 17

Association between Common Genetic Variants in the Opioid Pathway and Smoking Behaviors in Chinese Men

Fang, J., Wang, X., & He, B. (2014) · Behavioral and Brain Functions · doi:10.1186/1744-9081-10-2 · Cited by 17

Initial responses to the first dose of nicotine in novel smokers: The role of exposure to environmental smoking and genetic predisposition

Schuck, K., Otten, R., Engels, R. C. M. E., & Kleinjan, M. (2014) · Psychology and Health · doi:10.1080/08870446.2014.884222 · Cited by 16

Extensive Changes in the Expression of the Opioid Genes between Humans and Chimpanzees

Cruz-Gordillo, P., Fedrigo, O., Wray, G. A., & Babbitt, C. C. (2010) · Brain, Behavior and Evolution · doi:10.1159/000320968 · Cited by 16

Association of Polymorphisms of the Mu Opioid Receptor Gene with the Severity of HIV Infection and Response to HIV Treatment

Proudnikov, D., Randesi, M., Levran, O., Crystal, H., Dorn, M., Ott, J., Ho, A., & Kreek, M. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis264 · Cited by 16

Polymorphism of Opioid Receptors μ1 in Highly Hypnotizable Subjects

Presciuttini, S., Curcio, M., Sciarrino, R., Scatena, F., Jensen, M. P., & Santarcangelo, E. L. (2018) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2018.1396128 · Cited by 17

Nicotine Withdrawal Sensitivity, Linkage to chr6q26, and Association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) Sample

Hardin, J., He, Y., Javitz, H. S., Wessel, J., Krasnow, R. E., Tildesley, E. A., Hops, H., Swan, G. E., & Bergen, A. W. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0960 · Cited by 16

Molecular Biology of Mu Opioid Receptors

Pan, Y., & Pasternak, G. W. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_6 · Cited by 16

Next-generation DNA sequencing-based assay for measuring allelic expression imbalance (AEI) of candidate neuropsychiatric disorder genes in human brain

Xu, X. H., Wang, H., Zhu, M., Sun, Y., Yu, T., He, Q., Wang, J., Chen, L., & Saffen, D. W. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-518 · Cited by 15

Translational Research on Nicotine Dependence

Falcone, M., Lee, B., Lerman, C. E., & Blendy, J. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_5005 · Cited by 15

A cis‐ eQTL in OPRM 1 is Associated with Subjective Response to Alcohol and Alcohol Use

Otto, J. M., Gizer, I. R., Deak, J. D., Fleming, K. A., & Bartholow, B. D. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13369 · Cited by 15

The impact of OPRM1 ’s Genetic Polymorphisms on Methadone Maintenance Treatment in Opioid Addicts: A Systematic Review

Oueslati, B., MOULA, O., & Ghachem, R. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0017 · Cited by 15

Convergent Balancing Selection on the Mu-Opioid Receptor in Primates

Sweeney, C. G., Rando, J. M., Panas, H. N., Miller, G. M., Platt, D. M., & Vallender, E. J. (2017) · Molecular Biology and Evolution · doi:10.1093/molbev/msx105 · Cited by 16

CYP2C9 Promoter Variable Number Tandem Repeat Polymorphism Regulates mRNA Expression in Human Livers

Wang, D., Sun, X., Gong, Y., Gawronski, B. E., Langaee, T. Y., Shahin, M. H., Khalifa, S. I., & Johnson, J. A. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.044255 · Cited by 15

Alcohol addiction and the mu-opioid receptor

Berrettini, W. H. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.011 · Cited by 16

Rapid detection of single nucleotide polymorphisms using the MinION nanopore sequencer: a feasibility study for perioperative precision medicine

Tabata, Y., Matsuo, Y., Fujii, Y., Ohta, A., & Hirota, K. (2022) · JA Clinical Reports · doi:10.1186/s40981-022-00506-7 · Cited by 13

Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex

Kleinjan, M., Poelen, E. A. P., Engels, R. C. M. E., & Verhagen, M. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00422.x · Cited by 14

Pharmacogenomic Biomarkers: Validation Needed for both the Molecular Genetic Mechanism and Clinical Effect

Sadée, W. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.23 · Cited by 14

Developmental Considerations for the Use of Naltrexone in Children and Adolescents

Stancil, S. L., Abdel‐Rahman, S. M., & Wagner, J. (2021) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-26.7.675 · Cited by 14

Genetic Basis for Predicting Response to Naltrexone in the Treatment of Alcohol Dependence

Anton, R. F. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.6.655 · Cited by 14

Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol

Scarnati, M. S., Boreland, A. J., Joel, M., Hart, R. P., & Pang, Z. P. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.05.004 · Cited by 14

Nicotine Addiction: Past and Present

Office on Smoking (2010) · Cited by 14

Genetic Vulnerability to Opioid AddictionPreprint

Reed, B., & Kreek, M. J. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039735 · Cited by 14

Predictive models for fentanyl dose requirement and postoperative pain using clinical and genetic factors in patients undergoing major breast surgery

Kumar, S., Ramasamy, K., Sistla, S. C., Penumadu, P., Natarajan, H., Rao, U. S. C., Nair, S. N., Vasuki, V., & Kundra, P. (2022) · Pain · doi:10.1097/j.pain.0000000000002821 · Cited by 13

Allele-specific differences in ryanodine receptor 1 mRNA expression levels may contribute to phenotypic variability in malignant hyperthermia

Grievink, H., & Stowell, K. M. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-10 · Cited by 13

Opioid neuroscience for addiction medicine

Berrettini, W. H. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.030 · Cited by 13

Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism −1438 A/G on Speed-Dating Success

Wu, K. L., Chen, C., Moyzis, R. K., Greenberger, E., & Yu, Z. (2016) · Human Nature · doi:10.1007/s12110-016-9257-8 · Cited by 14

Variation of the human mu-opioid receptor (OPRM1) gene predicts vulnerability to frustration

Daniel, A. M., Rushing, B. G., & Menchaca, K. Y. T. (2020) · Scientific Reports · doi:10.1038/s41598-020-78783-4 · Cited by 13

Effect of OPRM1 and stressful life events on symptoms of major depression in African American adolescents

Swann, G., Byck, G. R., Dick, D. M., Alıev, F., Latendresse, S. J., Riley, B. P., Kertes, D. A., Sun, C., Salvatore, J. E., Bolland, J. M., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.020 · Cited by 14

Genetics of idiopathic generalized epilepsy: An overview

Munshi, A., Prasad, D. K. V., & Satyanarayana, U. (2013) · Neurology India · doi:10.4103/0028-3886.125240 · Cited by 13

Association of the OPRM1 and COMT genes’ polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?

Chatti, I., Creveaux, I., Woillard, J., Lambert-Langlais, S., Amara, A., Fatma, L. B., Saâd, A., Gribaa, M., & Libert, F. (2016) · Therapies · doi:10.1016/j.therap.2016.04.004 · Cited by 13

A case report of mesenteric heterotopic ossification: Histopathologic and genetic findings

Matthew, A., Fyfe, B. S., Thomas, S. V., Egan, K. P., Xu, M., Smith, A. G., Kaplan, F. S., Shore, E. M., & Pignolo, R. J. (2018) · Bone · doi:10.1016/j.bone.2018.01.006 · Cited by 13

Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy

Ray, R., Schnoll, R. A., & Lerman, C. E. (2007) · CNS Drugs · doi:10.2165/00023210-200721070-00001 · Cited by 14

Duration of analgesia and pruritus following intrathecal fentanyl for labour analgesia: no significant effect of A118G μ-opioid receptor polymorphism, but a marked effect of ethnically distinct hospital populations

Ginosar, Y., Birnbach, D. J., Shirov, T., Arheart, K. L., Caraco, Y., & Davidson, E. M. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet075 · Cited by 13

Perspectives on Current Directions in the Neurobiology of Addiction Disorders Relevant to Genetic Risk Factors

Hurd, Y. L. (2006) · CNS Spectrums · doi:10.1017/s1092852900015005 · Cited by 13

Catechol-O-methyltransferase polymorphisms do not play a significant role in pain perception in male Chinese Han population

Xiang, X., Jiang, Y., Ni, Y., Fan, M., Shen, F., Wang, X., Han, J., & Cui, C. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00162.2011 · Cited by 12

Subjective Response as a Consideration in the Pharmacogenetics of Alcoholism Treatment

Roche, D. J., & Ray, L. A. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.143 · Cited by 13

Pharmacogenetics of Obesity Drug Therapy

Guzman, A. K., Ding, M., Xie, Y., & Martin, K. A. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140811120307 · Cited by 12

Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial

Anton, R. F., Voronin, K. E., Book, S. W., Latham, P. K., Randall, P. K., Glen, W. B., Hoffman, M., & Schacht, J. P. (2020) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14431 · Cited by 12

Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder

Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mhmb.061314 · Cited by 12

Association of Mu opioid receptor (A118G) and BDNF (G196A) polymorphisms with rehabilitation-induced cortical inhibition and analgesic response in chronic osteoarthritis pain

Gonçalves, F. D. T., Pacheco‐Barrios, K., Rebello‐Sanchez, I., Castelo-Branco, L., de Melo, P. S., Parente, J., Cardenas‐Rojas, A., Firigato, I., Pessotto, A. V., Imamura, M., et al. (2022) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2022.100330 · Cited by 12

Genetic Contributions to Labor Pain and Progress

Landau, R. (2013) · Clinics in Perinatology · doi:10.1016/j.clp.2013.05.014 · Cited by 12

Variation in OPRM1 and Risk of Suicidal Behavior in Drug‐Dependent Individuals

Arias, A. J., Chan, G., Gelernter, J. E., Farrer, L. A., & Kranzler, H. R. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00195.x · Cited by 12

[N-Allyl-Dmt1]-Endomorphins Are μ-Opioid Receptor Antagonists Lacking Inverse Agonist Properties

Marczak, E. D., Jinsmaa, Y., Li, T., Bryant, S. D., Tsuda, Y., Okada, Y., & Lazarus, L. H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125807 · Cited by 12

Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response

Xie, X., Gu, J., Zhuang, D., Zhou, Y., Chen, X., Shen, W., Li, L., Liu, Y., Xu, W., Hong, Q., et al. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24750 · Cited by 11

A Novel and Rapid Method of Determining the Effect of Unclassified MLH1 Genetic Variants on Differential Allelic Expression

Perera, S., Li, B., Tsitsikotas, S., Ramyar, L., Pollett, A. F., Semotiuk, K., & Bapat, B. V. (2010) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090240 · Cited by 11

Allelic mRNA expression imbalance in C-type lectins reveals a frequent regulatory SNP in the human surfactant protein A (SP-A) gene

Azad, A. K., Curtis, A., Papp, A. C., Webb, A., Knoell, D. L., Sadée, W., & Schlesinger, L. S. (2013) · Genes and Immunity · doi:10.1038/gene.2012.61 · Cited by 11

Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment

Bozinoff, N., & Foll, B. L. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1507736 · Cited by 11

Complex Role of Hypnotizability in the Cognitive Control of Pain

Santarcangelo, E. L., & Consoli, S. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02272 · Cited by 11

A 6 V polymorphism of the human μ ‐opioid receptor decreases signalling of morphine and endogenous opioids in vitro

Knapman, A., Santiago, M., & Connor, M. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13047 · Cited by 11

Mechanistic role of a disease-associated genetic variant within the ADAM33 asthma susceptibility gene

Mastro, R. G. D., Turenne, L., Giese, H., Keith, T. P., Eerdewegh, P. V., May, K. J., & Little, R. D. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-46 · Cited by 11

Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs

Xu, Y., & Johnson, A. P. (2013) · Pain Research and Treatment · doi:10.1155/2013/943014 · Cited by 11

Independent and Interactive Effects of OPRM1 and DAT1 Polymorphisms on Alcohol Consumption and Subjective Responses in Social Drinkers

Weerts, E. M., Wand, G. S., Maher, B. S., Xu, X., Stephens, M. A. C., Yang, X., & McCaul, M. E. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13384 · Cited by 11

Pathophysiology of Chronic Pain

Lyndon, S. (2026) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000001362 · Cited by 11

Increased ethanol drinking in “humanized” mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms

Henderson, A. N., Lowe, T. E., Tian, X., & Morgan, D. J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.07.017 · Cited by 10

Translational genetic approaches to substance use disorders: bridging the gap between mice and humans

Palmer, A. A., & de Wit, H. (2011) · Human Genetics · doi:10.1007/s00439-011-1123-5 · Cited by 9

Allele-specific expression identified rs2509956 as a novel long-distance cis-regulatory SNP for SCGB1A1, an important gene for multiple pulmonary diseases.

Li, X., Peng, T., Gao, J., Feng, J.-G., Wu, D.-D., Yang, T., Zhong, L., Fu, W.-P., & Sun, C. (2019) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.00275.2018 · Cited by 8

Murine model of OPRM1 A118G alters oxycodone self-administration and locomotor activation, but not conditioned place preference

Collins, D., Zhang, Y., Blendy, J. A., & Kreek, M. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107864 · Cited by 11

Multifocal Analysis of Acute Pain After Third Molar Removal

Weckwerth, G. M., Dionísio, T. J., Costa, Y. M., Gonçalves, P. Z., Oliveira, G. M., Torres, E. A., Bonjardim, L. R., de Faria, F. A. C., Calvo, A. M., Moore, T., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643874 · Cited by 10

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

Chawar, C., Hillmer, A., Sanger, S., D’Elia, A., Panesar, B., Guan, L., Xie, D. X., Bansal, N., Abdullah, A., Kapczinski, F. P., et al. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00278-y · Cited by 10

Involvement of the mu-opioid receptor gene polymorphism A118G in the efficacy of detoxification of alcohol dependent patients

Marini, V., Fucile, C., Zuccoli, M. L., Testino, G., Sumberaz, A., Robbiano, L., Martelli, A., & Mattioli, F. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.09.015 · Cited by 10

Mu opioid receptor gene variant modulates subjective response to smoked cannabis.

Bourgault, Z., Matheson, J., Mann, R. E., Brands, B., Wickens, C. M., Tiwari, A. K., Zai, C. C. H., Kennedy, J. L., & Foll, B. L. (2022) · PubMed Central · Cited by 9

Associations of the A118G OPRM1 polymorphism with sociotropy and interpersonal sensitivity

Suzuki, A., Shirata, T., Noto, K., Matsumoto, Y., Muraosa, H., Abe, M., Goto, K., & Otani, K. (2022) · Brain and Behavior · doi:10.1002/brb3.2674 · Cited by 8

Shared Genetic Regulatory Networks Contribute to Neuropathic and Inflammatory Pain: Multi-Omics Systems Analysis

Ye, F., Du, L., Huang, W., & Wang, S. (2022) · Biomolecules · doi:10.3390/biom12101454 · Cited by 9

Opioid Addiction and Opioid Receptor Dimerization: Structural Modeling of the OPRD1 and OPRM1 Heterodimer and Its Signaling Pathways

Wu, B., Hand, W. R., & Alexov, E. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910290 · Cited by 9

Impact of Genetic Variants on Postoperative Pain and Fentanyl Dose Requirement in Patients Undergoing Major Breast Surgery: A Candidate Gene Association Study

Kumar, S., Ramasamy, K., Sistla, S. C., Penumadu, P., Natarajan, H., Nair, S. N., Uppugunduri, C. R. S., Vasuki, V., & Kundra, P. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006330 · Cited by 9

Overview of Genetic Analysis of Human Opioid Receptors

Spampinato, S. M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1708-2_1 · Cited by 9

Variation in the μ-Opioid Receptor Gene ( OPRM1 ) Does Not Moderate Social-Rejection Sensitivity in Humans

Persson, E., Asutay, E., Heilig, M. A., Löfberg, A., Pedersen, N. L., Västfjäll, D., & Tinghög, G. (2019) · Psychological Science · doi:10.1177/0956797619849894 · Cited by 12

Translational Molecular Approaches in Substance Abuse Research

Fulton, S. L., & Maze, I. S. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_259 · Cited by 9

CYP450 polymorphisms and clinical pharmacogenetics of ibuprofen after lower third molar extraction

Weckwerth, G. M., Dionísio, T. J., Costa, Y. M., Colombini-Ishiquiriama, B. L., Oliveira, G. M., Torres, E. A., Bonjardim, L. R., Calvo, A. M., Moore, T., Absher, D., et al. (2020) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-020-03046-0 · Cited by 9

No Association of Single Nucleotide Polymorphisms in the μ‐Opioid Receptor Subunit Gene with Idiopathic Generalized Epilepsy

Barratt, C., Lai, T. J., Nashef, L. A. M., Valentı́n, A., Fisniku, L. K., Moran, N. F., Asherson, P. J., & MAKOFF, A. J. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00844.x · Cited by 9

Letting the Gene out of the Bottle

Belfer, I., Young, E. E., & Diatchenko, L. B. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000404 · Cited by 9

Neural Network Connectivity Following Opioid Dependence is Altered by a Common Genetic Variant in the µ-Opioid Receptor,OPRM1A118G

Xie, Y., Brynildsen, J. K., Windisch, K. A., & Blendy, J. A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1492-23.2023 · Cited by 8

Impact of genetic and non-genetic factors on clinical responses to prochlorperazine in oxycodone-treated cancer patients

Tashiro, M., Naito, T., Ohnishi, K., Kagawa, Y., & Kawakami, J. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.12.011 · Cited by 8

Epigenetic and Genetic Factors Associated With Opioid Use Disorder: Are These Relevant to African American Populations

Blackwood, C. A., & Cadet, J. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.798362 · Cited by 11

Pharmacological data science perspective on fatal incidents of morphine treatment

Noufal, Y., Kringel, D., Toennes, S. W., Dudziak, R., & Lötsch, J. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108312 · Cited by 8

Developing Consensus on Tobacco Control and Research

Backinger, C. L., & O’Connell, M. E. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.09.012 · Cited by 8

The genetic architecture of autism spectrum disorders (ASDs) and the potential importance of common regulatory genetic variants

Saffen, D. W. (2015) · Science China Life Sciences · doi:10.1007/s11427-012-4336-5 · Cited by 8

How the Brain Feels the Hurt of Heartbreak: Examining the Neurobiological Overlap Between Social and Physical Pain

Tchalova, K., & Eisenberger, N. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00144-5 · Cited by 10

Gene Variant Suggests Link To Addiction Vulnerability

Milne, D. (2005) · Psychiatric News · doi:10.1176/pn.40.21.0028

Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?

Mura, E., Govoni, S. M., Racchi, M., Carossa, V., Ranzani, G. N., Allegri, M., & van Schaik, R. H. N. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7

Single‐nucleotide polymorphism (A118G) in exon 1 ofOPRM1gene causes alteration in downstream signaling by mu‐opioid receptor and may contribute to the genetic risk for addiction

Deb, I., Chakraborty, J., Gangopadhyay, P. K., Choudhury, S. R., & Das, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06472.x · Cited by 105

OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models

Mague, S. D., & Blendy, J. A. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.12.016 · Cited by 138

Synaptic Regulation by OPRM1 Variants in Reward Neurocircuitry

Popova, D., Desai, N., Blendy, J. A., & Pang, Z. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2317-18.2019 · Cited by 22